Influences on the prescribing of new drugs.
BACKGROUND
The aim of this study was to identify the factors that influence prescribing of new drugs among general practitioners, endocrinologists and psychiatrists.


METHODS
Four focus groups were conducted with GPs, endocrinologists and psychiatrists on sources of awareness and influences on prescribing of new drugs.


RESULTS
Pharmaceutical companies were the most important source for becoming aware of new drugs. There were many influences on the decision to prescribe a new drug, the most important being efficacy, safety, cost and advantage over existing therapies. Endocrinologists placed greater emphasis on evidence from clinical trials and scientific conferences, and psychiatrists and GPs placed more weight on pharmaceutical representatives, colleagues and specialists.


CONCLUSIONS
New drug prescribing occurs in a complex environment with many influences. Effective interventions to promote rational, safe and effective prescribing of new drugs will need to be cognisant of these factors.
Tobin
Luke
L
National Prescribing Service, New South Wales.
de Almedia Neto
Abelio C
AC
Wutzke
Sonia
S
Patterson
Craig
C
Mackson
Judith
J
Weekes
Lynn
L
Williamson
Margaret
M
D001291:Attitude of Health Personnel; D001315:Australia; D001364:Awareness; D005194:Family Practice / Q000639:trends*; D017144:Focus Groups; D006801:Humans; D008511:Medicine / Q000639:trends; D004364:Pharmaceutical Preparations / Q000008:administration & dosage*; D010818:Practice Patterns, Physicians' / Q000639:trends*; D013038:Specialization
D004364:Pharmaceutical Preparations